AGP Picks
View all

Medically Modern launches endocrinology partnership for CGM and insulin pump workflows

Sep. 8, 2026
By AI, Created 13:00 UTC, Sep 08, 2026, AGP -

Medically Modern has started a new partnership with a multi-location endocrinology practice in Northern Virginia to handle prior authorization, fulfillment and resupply tracking for CGM and insulin pump referrals. The model is meant to cut administrative work for practices while helping patients stay on track for payer-required visits that keep coverage active.

Why it matters: - Endocrinology practices often lose time to paperwork tied to CGM and insulin pump prescribing. - Medically Modern’s model shifts prior authorization, fulfillment and resupply tracking away from the practice. - The partnership is designed to help patients avoid coverage interruptions when six-month follow-up visits are required by payers. - The company is offering the same partnership approach to endocrinology and physician practices nationwide.

What happened: - Medically Modern announced a new endocrinology partnership with an independent, multi-location practice in Northern Virginia. - The DME supplier said it will manage prior authorization and fulfillment for the practice’s CGM and insulin pump referrals. - The practice’s care team gets real-time visibility into each referred patient’s onboarding status, ongoing resupply orders and last visit date. - The partner practice cares for more than 10,000 diabetes patients.

The details: - Onboarding visibility covers medical necessity documentation, insurance verification, onboarding and first shipment. - Medically Modern monitors the six-month visit window that many payers use to decide whether CGM coverage continues. - When a patient nears that threshold without a visit, Medically Modern works with the practice to schedule the patient before a resupply order is disrupted. - The company says its onboarding process starts with each practice’s biggest pain points, including pharmacy-versus-DME routing, six-month visits and supply reliability. - Medically Modern builds technology configured to each practice’s workflow. - Providers keep full control over patient referrals. - Participation in the program does not affect referral volume. - Clinical decisions stay with the patient’s treating providers. - Coverage and patient cost-sharing vary by plan, and Medically Modern verifies benefits before fulfillment. - Medically Modern works directly with diabetes technology manufacturers. - The company serves patients across Medicare, Medicare Advantage and nearly all major commercial payers. - Medically Modern says it serves more than 2,000 patients in all 50 states. - The company says its payer network covers more than 85% of U.S. lives. - Medically Modern is headquartered in New York, New York. - The company specializes in home delivery of continuous glucose monitors, insulin pumps and related diabetes supplies.

Between the lines: - The partnership reflects a broader push to turn diabetes supply management into a workflow service for practices, not just a fulfillment task. - The company is positioning technology and compliance infrastructure as the reason practices can offload administrative work without giving up clinical control. - Medically Modern says it operates under executed business associate agreements and maintains internal compliance policies covering HIPAA, the federal Anti-Kickback Statute and the Stark Law. - Corey Deutsch, founder and CEO, said the company moved into the partnership strategy after hearing repeated complaints from providers about paperwork for FreeStyle Libre, Dexcom and insulin pumps. - Josh Hoffman, lead engineer, said the technology-first model gives providers and staff time back and helps keep patients on schedule for payer-required visits.

What’s next: - Medically Modern is seeking additional practice partners nationwide. - Interested practices can contact the company at records@medicallymodern.com. - The company is also directing readers to learn more at Medically Modern.

The bottom line: - Medically Modern is betting that less paperwork and tighter tracking can make CGM and insulin pump prescribing easier for both practices and patients.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.